1 year return (CAGR)
-97.33%
Aslan Pharmaceuticals Ltd ADR Exchange (NASDAQ, USD)
ASLN
-
-0.10 (-14.27%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-82.50%
5 year return (CAGR)
-65.85%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.70M
Price/Sales
0.14
Ent value
22.25M
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-17.52%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.63 |
| Daily high | 0.70 |
| Daily low | 0.60 |
| Daily Volume | 762K |
| 1y analyst estimate | 72.00 |
| Beta | 1.40 |
| EPS (TTM) | -17.88 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ASLN | S&P500 | |
| Current price drop from All-time high | -99.85% | -2.16% |
| Highest price drop | -99.85% | -56.47% |
| Date of highest drop | 18 Jul 2024 | 9 Mar 2009 |
| Avg drop from high | -78.83% | -10.68% |
| Avg time to new high | 195 days | 12 days |
| Max time to new high | 1538 days | 1805 days |
News
No items found